Delivery Order SPE2DX22D0010-SPE2D826FBK59
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 10mg, with a ceiling value of $1,049.57. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on November 25, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 30, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with a ceiling value of $1,055.37 and an ultimate completion date of October 1, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Amphetamine Mix (AD) Extended Release capsules in 20 mg dosage. This competitively awarded, non-set-aside delivery order carries a firm fixed price ceiling value of $1,214.30, with an ultimate completion date of November 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, with a ceiling value of $2,292.80 and an ultimate completion date of December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 15mg with a ceiling value of $1,161.92. The contract was awarded on November 14, 2025, with an ultimate completion date of November 17, 2025, and employs firm fixed price terms with no set-aside designation. Performance will take place at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, with a ceiling value of $2,137.71. This competitively awarded, firm fixed-price delivery order was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules, 25mg, with a ceiling value of $4,993.24. This is a firm fixed price delivery order awarded on November 6, 2025, with an ultimate completion date of November 7, 2025. The contract employs no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $4,408.02 delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25 mg, with a completion date of September 9, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military healthcare systems....
- The Defense Logistics Agency Medical Supply Chain awarded a $2,727.34 delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) Extended-Release Capsules, 20mg, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The order was placed at the contractor's primary location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $3,866.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25mg. The contract was executed on June 23, 2025, with an ultimate completion date of June 24, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This was a competitive award with no set-aside designation. This delivery order represents a child contract under...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBK59Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 10mg, with a contract ceiling value of $2,071.44 and a completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains on a competitive basis, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/30/25 |